SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
ASMPT Limited (ASMVY) trades at a trailing P/E of 2.5. Trailing earnings yield is 40.00%. PEG 0.02 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (2.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.02); earnings yield beats bond yields (40.00%).
- PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 40.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 64/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ASMVY
Valuation Multiples
P/E (TTM)2.5
Forward P/EN/A
PEG Ratio0.02
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.16
EV/EBITDA0.0
Per Share Data
EPS (TTM)$19.38
Book Value / Share$0.00
Revenue / Share$295.55
FCF / Share$0.00
Yields & Fair Value
Earnings Yield40.00%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$10.80 |
$14.25B |
$1.46B |
10.3% |
| 2017 |
$19.05 |
$17.52B |
$2.82B |
16.1% |
| 2018 |
$16.32 |
$19.55B |
$2.22B |
11.3% |
| 2019 |
$4.56 |
$15.88B |
$619.25M |
3.9% |
| 2020 |
$5.58 |
$16.89B |
$1.62B |
9.6% |
| 2021 |
$23.07 |
$21.95B |
$3.17B |
14.4% |
| 2022 |
$18.99 |
$19.36B |
$2.62B |
13.5% |
| 2023 |
$5.19 |
$14.7B |
$715.35M |
4.9% |
| 2024 |
$7.47 |
$13.23B |
$345.26M |
2.6% |
| 2025 |
$19.38 |
$13.71B |
$900.32M |
6.6% |
